PQ 408
408. Deputy Mary Lou McDonald asked the Minister for Health if the HSE Leadership Team met on 14 May 2019 to consider additional information submitted by the manufacturer of the drug Spinraza; and when the team will make a final decision on the reimbursement of the drug based on this information. [21754/19]
Introduced
21 May 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
21 May 2019
Summary
408. Deputy Mary Lou McDonald asked the Minister for Health if the HSE Leadership Team met on 14 May 2019 to consider additional information submitted by the manufacturer of the drug Spinraza; and when the team will make a final decision on the reimbursement of the drug based on this information. [21754/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 21 May 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-05-21/408/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-05-21/pq_408